Page 1 od 20 rezultati
CROSS-REFERENCE TO RELATED APPLICATIONS
Not Applicable.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable.
INCORPORATION BY REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
FIELD OF THE INVENTION
The present invention relates generally to
CROSS-REFERENCE TO RELATED APPLICATIONS
Not Applicable.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable.
INCORPORATION BY REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not Applicable.
TECHNICAL FIELD
The present invention relates to generally to anti-inflammatory
CROSS-REFERENCE TO RELATED APPLICATIONS
This disclosure claims the benefit of priority to Indian Patent Application No. 201631031742, filed Sep. 17, 2016, the disclosure of which is incorporated herein in its entirety.
FIELD OF THE INVENTION
The present invention relates to formulation for reducing
BACKGROUND
Technical Field
The disclosure relates to a composition containing essential oils and plant extracts for treating, vaginal infection and/or inflammation. The composition may also enable the reestablishment of the normal microbiota shortly after the administration of the
BACKGROUND OF THE INVENTION
Research into the mechanism of inflammatory pain led to the discovery of the biochemical pathway associated with inflammation. One such example of chronic inflammatory pain is osteoarthritis. The elucidation of this pathway led to the association of the pro-inflammatory
BACKGROUND AND FIELD OF THE INVENTION
Complex carbohydrates, for purposes of this invention are defined as any polymer comprising more than two sugar moieties and would thus include such classes of compounds as polysaccharides and oligosaccharides. Polysaccharides include glycosaminoglycans and
BACKGROUND AND FIELD OF THE INVENTION
Complex carbohydrates, for purposes of this invention are defined as any polymer comprising more than two sugar moieties and would thus include such classes of and oliosaccharides. Polysaccharides include glycosaminoglycans and mannans whereas oligosaccharides
BACKGROUND AND FIELD OF THE INVENTION
The invention relates to a method of preventing and treating diseases and conditions of mammals associated with the adhesion, metastatic and coronary cascades comprising applying a composition of complex carbohydrates and essential oils topically, orally or
BACKGROUND AND FIELD OF THE INVENTION
The invention relates to a method of preventing and treating diseases and conditions of mammals associated with the adhesion, metastatic and coronary cascades comprising applying a composition of complex carbohydrates and essential oils topically, orally or
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is broadly concerned with improved oral rinses and mouthwashes and methods of making and using the same.
2. Description of the Prior Art
A variety of mouthwashes and oral rinses have been developed for treatment of
FIELD OF THE INVENTION
The present invention relates generally to a composition comprising a complex mixture of active ingredients exhibiting selective inhibition of inducible cyclooxygenase-2 (COX-2) and methods for selective inhibition of COX-2 mediated synthesis of prostaglandins.
More
FIELD OF THE INVENTION
The present invention relates generally to a composition comprising a complex mixture of active ingredients exhibiting selective inhibition of inducible cyclooxygenase-2 (COX-2) and method for selective inhibition of COX-2 mediated synthesis of prostaglandins. More
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a composition comprising a complex mixture of active ingredients exhibiting selective inhibition of inducible cyclooxygenase-2 (COX-2) and method for selective inhibition of COX-2 mediated synthesis of
FIELD OF THE INVENTION
The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of
FIELD OF THE INVENTION
The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of